A pilot study of tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy.R. Raab, Adam S. Asch, David Spetzler et al.|Journal of Clinical Oncology|2011Cited by 3